Shares of Genflow Biosciences plc (LON:GENF – Get Free Report) dropped 9.1% during trading on Thursday . The company traded as low as GBX 1.99 and last traded at GBX 2. Approximately 2,734,865 shares were traded during trading, an increase of 21% from the average session volume of 2,261,087 shares. The stock had previously closed at GBX 2.20.
Genflow Biosciences Price Performance
The firm has a 50-day moving average price of GBX 2.23 and a two-hundred day moving average price of GBX 2.04. The company has a market capitalization of £11.33 million, a P/E ratio of -6.02 and a beta of 2.31.
Genflow Biosciences (LON:GENF – Get Free Report) last announced its earnings results on Thursday, April 30th. The company reported GBX (0.33) earnings per share (EPS) for the quarter. Genflow Biosciences had a positive return on equity of 191.29% and a negative net margin of 300.94%.
Genflow Biosciences Company Profile
Genflow Biosciences plc is a UK based biotech company with R&D facilities in Belgium and a US office in Cambridge, MA, driven by one mission: to deliver therapeutics that potentially halt or slow the ageing process in humans and dogs.
The company’s lead compound works through the delivery of a centenarian variant of the SIRT6 gene and has yielded promising preclinical results.
Read More
- Five stocks we like better than Genflow Biosciences
- MarketBeat Week in Review – 06/29 – 07/03
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
Receive News & Ratings for Genflow Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genflow Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
